Off-label use of approved drugs: therapeutic opportunity and challenges
- PMID: 14978188
- DOI: 10.1097/01.asn.0000118323.41076.01
Off-label use of approved drugs: therapeutic opportunity and challenges
Comment on
-
Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.J Am Soc Nephrol. 2004 Mar;15(3):717-21. doi: 10.1097/01.asn.0000114554.67106.28. J Am Soc Nephrol. 2004. PMID: 14978174 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
